Literature DB >> 55349

Effect of flurazepam on sleep spindles and K-complexes.

L C Johnson, K Hanson, R G Bickford.   

Abstract

In this research, a quantitative study of the EEG from 5 subjects permitted a detailed analysis of the effect of 30 mg of flurazepam administered over 7 nights. Four placebo baseline nights and 3 placebo withdrawal nights were also recorded. For 4 of the subjects, a nondrug and nonplacebo follow-up record was obtained 4 to 6 weeks later. The subjects were 4 females, 1 male, age range 23-42. All complained of either sleep onset greater than 45 min, sleep length of less than 6 h, or two or more sleep awakenings. Compressed spectral analysis yielded a computer-generated somnogram on each of the 15 nights of sleep, and an automated spindle detector was used to count and measure the duration of spindle bursts with frequencies of 12.25-15.5 c/sec on baseline nights 3 and 4, drug nights 1, 2, 3 and 7, on the 3rd withdrawal night, and on the 4-6 week followup record. K-complexes were scored visually on the 4th baseline and 7th drug nights. There were no significant differences in spindle rate per minute among baseline nights and the follow-up record. By the 2nd drug night, spindle rate had significantly increased over the baseline rate. Linear contrast analysis indicated there was a significant increase of spindle rate over drug nights. All 5 subjects showed this pattern of increase. In contrast to the increase in spindle activity, the rate per minute of K-complexes significantly decreased during drug administration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55349     DOI: 10.1016/0013-4694(76)90180-2

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  11 in total

1.  Improved procedure of complex demodulation and an application to frequency analysis of sleep spindles in EEG.

Authors:  Y L Hao; Y Ueda; N Ishii
Journal:  Med Biol Eng Comput       Date:  1992-07       Impact factor: 2.602

Review 2.  Hypnotics and sleep physiology: a consensus report. European Sleep Research Society, Committee on Hypnotics and Sleep Physiology.

Authors:  A A Borbély; T Akerstedt; O Benoit; F Holsboer; I Oswald
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1991       Impact factor: 5.270

3.  Mood and performance of poor sleepers during repeated use of flurazepam.

Authors:  M W Church; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

4.  Using Oscillating Sounds to Manipulate Sleep Spindles.

Authors:  James W Antony; Ken A Paller
Journal:  Sleep       Date:  2017-03-01       Impact factor: 5.849

5.  Sleep studies in clinical pharmacology.

Authors:  I Oswald
Journal:  Br J Clin Pharmacol       Date:  1980-10       Impact factor: 4.335

6.  Changes in sleep spindle activity of subject with chronic somatosensitive and sensorial deficits. Preliminary results.

Authors:  A Scrofani; M Cioni; S Filetti; F Lanaia; G Pennisi; R Bella; A Grasso
Journal:  Ital J Neurol Sci       Date:  1996-12

7.  Concomitant BDNF and sleep slow wave changes indicate ketamine-induced plasticity in major depressive disorder.

Authors:  Wallace C Duncan; Simone Sarasso; Fabio Ferrarelli; Jessica Selter; Brady A Riedner; Nadia S Hejazi; Peixiong Yuan; Nancy Brutsche; Husseini K Manji; Giulio Tononi; Carlos A Zarate
Journal:  Int J Neuropsychopharmacol       Date:  2012-06-07       Impact factor: 5.176

8.  Sleep in a sitting position: effect of triazolam on sleep stages and EEG power spectra.

Authors:  D Aeschbach; C Cajochen; I Tobler; D J Dijk; A A Borbély
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

Review 9.  Alcohol and the sleeping brain.

Authors:  Ian M Colrain; Christian L Nicholas; Fiona C Baker
Journal:  Handb Clin Neurol       Date:  2014

10.  An intra-K-complex oscillation with independent and labile frequency and topography in NREM sleep.

Authors:  Vasileios Kokkinos; Andreas M Koupparis; George K Kostopoulos
Journal:  Front Hum Neurosci       Date:  2013-04-26       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.